maximum weight loss tirzepatide mounjaro clinical trials Most people think all GLP-1 medications are basically the same. They're not. Ozempic. Wegovy. Mounjaro. Zepbound. Different approvals. Different dosing. Different weight-loss outcomes. Different side-effect profiles. The “best” one isn't the most Tirzepatide (Mounjaro) for the Treatment

The majority of gastrointestinal events were mild or moderate in severity and occurred during the first 30 weeks

Recommended Storage Conditions Store in a cool, dry environment Avoid direct sunlight and excessive heat Minimise temperature fluctuations Follow standard laboratory handling procedures Proper storage conditions help preserve stability and research performance

For more information, please contact: MEDIA CONTACTS: Melissa Wilton, Head of Communications & Engagement, Butterfly Ph: 0402 259 652| E: [email protected] Breanna Guterres, Eating Disorders Victoria Director of Communications, Advocacy and Engagement Ph: 0431 717 177 E: [email protected] Belinda Chelius, Eating Disorders Queensland CEO Ph:0405 906 466 E: [email protected] Jaimie Robertson, Eating Disorders Families Australia Head of Stakeholder Engagement E: [email protected] Melissa Zea, Australia & New Zealand Academy for Eating Disorders Ph: 0478 142 901 E: [email protected] Megan Tombs, EDANZ Board Director [email protected]

Always consult a qualified healthcare professional before beginning or changing any treatment

Mounjaro affects appetite and digestion, which can lead to weight reduction